Skip to main content

Evan Raff, MD

Assistant Professor of Medicine, Division of Hospital Medicine
Physician Service Leader, Direct Care Services at Chapel Hill

Specialty Areas

Quality improvement, patient safety, clinical education, and hepatology

Chronology

BA Summa cum laude: University of Louisville, 2007; MD: University of North Carolina School of Medicine, 2011; Resident: University of Alabama Internal Medicine Residency Program, 2011-2014; Assistant Professor of Medicine: University of Alabama at Birmingham, 2014-2017; Medical Officer of the Day: University of Alabama at Birmingham Hospital, 2015-2016; Inpatient Unit Medical Director: University of Alabama at Birmingham Hospitalist Service, 2016-2017; Assistant Professor of Medicine: University of North Carolina Hospital, 2017-present; Physician Service Leader, Direct Care Services at Chapel Hill, 2020-present.

Research/ Clinical Interests

Dr. Raff’s clinical and quality improvement interests are closely linked. His particular focus is on providing quality healthcare in an efficient manner and utilizing operational and system changes to accomplish these goals. He graduated from the University of Alabama at Birmingham Quality and Safety Academy in 2015. His quality improvement work to date has been to help develop a hospital-wide vascular access program and analyze factors contributing to re-admissions and hospital “super-utilizers.” He is currently working on ways in which to reduce central line associated bloodstream infections.

Bibliography

Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Alcoholic Liver Disease Presents at Advanced Stage and Progresses Faster Compared to Non-alcoholic Fatty Liver Disease. Ann Hepatol. 2016 Mar-Apr;15(2):183-9.

Ravi S, Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease. Dig Dis Sci. 2015 Dec;60(12):3788-93.

Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Ulrich S, Daly A, Day CP, Kuo YF, Singal AK. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease. Am J Gastroenterol. 2015 Jun;110(6):846-56.

Raff E, Kakati D, Bloomer J, Shoreibah M, Rasheed K, Singal A. Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases. J Clin and Transl Hepatol. 2015 Mar;3(1):9-16.

Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Alcoholic Liver Disease Presents at Advanced Stage and Progresses Faster Compared to Non-alcoholic Fatty Liver Disease. Ann Hepatol. 2016 Mar-Apr;15(2):183-9.

Raff E, Singal A. Optimal Management of Alcoholic Hepatitis. Minerva Gastroenterologica E Dietologica 2014 March;60(1):25-38.

 

evan-raff
  • Address

    101 Manning Drive

    Hospital Medicine

    CB# 7085

    Chapel Hill, NC 27599-7085